MoonLake Immunotherapeutics (MLTX)Healthcare | Biotechnology | Zug, Switzerland | NasdaqCM
14.99 USD
-0.54
(-3.477%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 15.28 +0.29 (1.935%) ⇧ (Aug. 28, 2026, 7:30 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 5:14 a.m. EDT
The long-term outlook is solidly positive, driven by a spectacular four-year price trajectory that has more than quadrupled (+464%) despite significant dilution events. The business shows resilience with two years of positive growth offsetting two years of decline, avoiding the 'multi-year decliner' penalty that would crush a rating. While the company is burning cash and lacks earnings, the balance sheet is fortress-like with a current ratio of 12.5x and manageable debt relative to cash, allowing it to fund its pipeline without immediate distress. The recent $200M follow-on offering caused a temporary price dislocation, but the retail attention on potential buyouts and positive trial data suggests the market is pricing in a catalyst event. Short-term, the stock is vulnerable to the immediate aftermath of the capital raise, trading below its 50-day average, which warrants a cautious stance until the dust settles. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.037462 |
| MSTL | 0.037542 |
| AutoETS | 0.054197 |
| AutoTheta | 0.058182 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 31% |
| H-stat | 0.41 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.391 |
| Excess Kurtosis | 0.59 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 23.712 |
| Market Cap | 1,275,749,248 |
| Forward P/E | -4.49 |
| Beta | 1.07 |
| Website | https://www.moonlaketx.com |
As of Aug. 22, 2026, 5:14 a.m. EDT: Speculators are heavily positioning for upside volatility with massive open interest walls at $30 and $50 strikes for 2027 expirations, while ATM IV remains elevated (~80%). However, put volume is concentrated near-the-money ($15-$16) for near-term expirations, suggesting a hedge against the immediate post-offering dip rather than a bearish bet on the long term.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.7348019 |
| Address1 | Dorfstrasse 29 |
| All Time High | 64.98 |
| All Time Low | 4.25 |
| Ask | 19.3 |
| Ask Size | 2 |
| Average Analyst Rating | 1.9 - Buy |
| Average Daily Volume10 Day | 1,123,090 |
| Average Daily Volume3 Month | 1,252,566 |
| Average Volume | 1,252,566 |
| Average Volume10Days | 1,123,090 |
| Beta | 1.068 |
| Bid | 11.09 |
| Bid Size | 2 |
| Book Value | 5.122 |
| City | Zug |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Switzerland |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 14.99 |
| Current Ratio | 12.558 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 15.765 |
| Day Low | 14.97 |
| Debt To Equity | 23.712 |
| Earnings Timestamp | 1,786,365,000 |
| Earnings Timestamp End | 1,793,881,800 |
| Earnings Timestamp Start | 1,793,881,800 |
| Ebitda | -265,099,008 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -3.17 |
| Enterprise Value | 840,251,200 |
| Eps Current Year | -3.33 |
| Eps Forward | -3.34213 |
| Eps Trailing Twelve Months | -3.71 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 18.4472 |
| Fifty Day Average Change | -3.457201 |
| Fifty Day Average Change Percent | -0.18741061 |
| Fifty Two Week Change Percent | -73.48019 |
| Fifty Two Week High | 62.75 |
| Fifty Two Week High Change | -47.760002 |
| Fifty Two Week High Change Percent | -0.76111555 |
| Fifty Two Week Low | 5.95 |
| Fifty Two Week Low Change | 9.04 |
| Fifty Two Week Low Change Percent | 1.5193278 |
| Fifty Two Week Range | 5.95 - 62.75 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,603,200,600,000 |
| Float Shares | 55,468,282 |
| Forward Eps | -3.34213 |
| Forward P E | -4.4851637 |
| Free Cashflow | -131,856,128 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 130 |
| Fullday Change | -0.54 |
| Fullday Change Percent | -3.47714 |
| Fullday Price | 15.28 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.081750005 |
| Held Percent Institutions | 0.87563 |
| Implied Shares Outstanding | 85,106,685 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland. |
| Long Name | MoonLake Immunotherapeutics |
| Market | us_market |
| Market Cap | 1,275,749,248 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_713684532 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -263,666,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,321,706,818 |
| Number Of Analyst Opinions | 13 |
| Open | 15.6 |
| Operating Cashflow | -225,180,992 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 41 415108022 |
| Post Market Change | 0.28999996 |
| Post Market Change Percent | 1.9346229 |
| Post Market Price | 15.28 |
| Post Market Time | 1,787,959,804 |
| Previous Close | 15.53 |
| Price Eps Current Year | -4.5015016 |
| Price Hint | 2 |
| Price To Book | 2.926591 |
| Profit Margins | 0.0 |
| Quick Ratio | 11.975 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.86667 |
| Region | US |
| Regular Market Change | -0.54 |
| Regular Market Change Percent | -3.47714 |
| Regular Market Day High | 15.765 |
| Regular Market Day Low | 14.97 |
| Regular Market Day Range | 14.97 - 15.765 |
| Regular Market Open | 15.6 |
| Regular Market Previous Close | 15.53 |
| Regular Market Price | 14.99 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 699,849 |
| Return On Assets | -0.32438 |
| Return On Equity | -0.67475 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 85,106,685 |
| Shares Percent Shares Out | 0.0801 |
| Shares Short | 6,819,147 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 6,334,566 |
| Short Name | MoonLake Immunotherapeutics |
| Short Percent Of Float | 0.1104 |
| Short Ratio | 5.61 |
| Source Interval | 15 |
| Symbol | MLTX |
| Target High Price | 50.0 |
| Target Low Price | 6.0 |
| Target Mean Price | 28.53846 |
| Target Median Price | 30.0 |
| Total Cash | 537,030,016 |
| Total Cash Per Share | 6.31 |
| Total Debt | 101,532,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.71 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 16.81785 |
| Two Hundred Day Average Change | -1.8278503 |
| Two Hundred Day Average Change Percent | -0.108685136 |
| Type Disp | Equity |
| Volume | 699,849 |
| Website | https://www.moonlaketx.com |
| Zip | 6,300 |